COMPOUNDS

The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.

Saved in:
Bibliographic Details
Main Authors Zhang, Xiaomin, Rivero, Raphael Anthony, Pero, Joseph E, Wang, Jian, Neipp, Christopher Ernst, Sender, Matthew Robert, Manas, Eric Steven, Patel, Vipulkumar Kantibhai, WAN, Zehong
Format Patent
LanguageEnglish
Published 20.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.
Bibliography:Application Number: US201916524238